Literature DB >> 7904274

Comparison of three cell cycle associated antigens as markers of proliferative activity and prognosis in breast carcinoma.

C E Gillett1, D M Barnes, R S Camplejohn.   

Abstract

The staining patterns obtained with two antibodies against proliferating cell nuclear antigen (PC10 and 19A2) and another cell cycle associated antibody (KiS1) were compared with each other and with a number of established prognostic markers of breast carcinoma. Although PC10 and 19A2 staining patterns were similar, only the latter was significantly associated with KiS1 antibody staining. These findings suggest that the two PCNA antibodies detect different epitopes. KiS1 was the only antibody to show an association with S phase fraction measured by flow cytometry (p < 0.001). It was also associated with histological grade (p = 0.003), oestrogen receptors (p = 0.045), and DNA index (p = 0.007). PC10 showed no association with any of the markers of prognosis, while 19A2 was associated with histological grade (p = 0.017) and oestrogen receptors (p = 0.043). The two PCNA antibodies do not seem to be of value in measuring proliferative activity nor do they seem to be associated with established markers of prognosis in breast cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7904274      PMCID: PMC501726          DOI: 10.1136/jcp.46.12.1126

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Flow cytometric characterisation of proliferating cell nuclear antigen using the monoclonal antibody PC10.

Authors:  G D Wilson; R S Camplejohn; C A Martindale; A Brock; D P Lane; D M Barnes
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

2.  Correlation of proliferative activity in breast tissue using PCNA/cyclin.

Authors:  S Battersby; T J Anderson
Journal:  Hum Pathol       Date:  1990-07       Impact factor: 3.466

3.  The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis.

Authors:  A L Woods; P A Hall; N A Shepherd; A M Hanby; N H Waseem; D P Lane; D A Levison
Journal:  Histopathology       Date:  1991-07       Impact factor: 5.087

4.  Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.

Authors:  S Jain; M I Filipe; P A Hall; N Waseem; D P Lane; D A Levison
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

5.  PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.

Authors:  E Leonardi; S Girlando; G Serio; F A Mauri; G Perrone; S Scampini; P Dalla Palma; M Barbareschi
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

6.  A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours.

Authors:  C C Yu; C D Fletcher; P L Newman; J R Goodlad; J C Burton; D A Levison
Journal:  J Pathol       Date:  1992-02       Impact factor: 7.996

7.  KiS1--a novel monoclonal antibody which recognizes proliferating cells: evaluation of its relationship to prognosis in mammary carcinoma.

Authors:  S A Sampson; H Kreipe; C E Gillett; P Smith; M A Chaudary; A Khan; K Wicks; R Parwaresch; D M Barnes
Journal:  J Pathol       Date:  1992-10       Impact factor: 7.996

8.  PC-10 antibody to proliferating cell nuclear antigen (PCNA) is not related to prognosis in human breast carcinoma.

Authors:  G Gasparini; S Meli; F Pozza; S Cazzavillan; P Bevilacqua
Journal:  Growth Regul       Date:  1992-12

9.  Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells.

Authors:  R S Camplejohn; A Brock; D M Barnes; C Gillett; B Raikundalia; H Kreipe; M R Parwaresch
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

  9 in total
  7 in total

1.  Determination of cell proliferation.

Authors:  D M Barnes; C E Gillett
Journal:  Clin Mol Pathol       Date:  1995-02

2.  Proliferation-associated nuclear antigen Ki-S1 is identical with topoisomerase II alpha. Delineation of a carboxy-terminal epitope with peptide antibodies.

Authors:  F Boege; A Andersen; S Jensen; R Zeidler; H Kreipe
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

3.  Evaluation of ER-α, ER-Β1 and ER-Β2 expression and correlation with clinicopathologic factors in invasive luminal subtype breast cancers.

Authors:  Huiming Zhang; Zhongtao Zhang; Lixue Xuan; Shan Zheng; Lei Guo; Qimin Zhan; Xiang Qu; Baoming Zhang; Yu Wang; Xiang Wang; Yongmei Song
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

4.  Differentiation of short-wavelength-sensitive cones by NADPH diaphorase histochemistry.

Authors:  H M Petry; H A Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

5.  Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma.

Authors:  P Bevilacqua; P Verderio; M Barbareschi; E Bonoldi; P Boracchi; P Dalla Palma; G Gasparini
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

6.  Prognostic significance of the proliferative activity in neuroblastoma.

Authors:  P Rudolph; T Lappe; B Hero; F Berthold; R Parwaresch; D Harms; D Schmidt
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

7.  Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNA.

Authors:  P J Hepburn; E Glynne-Jones; L Goddard; J M Gee; M E Harper
Journal:  Histochem J       Date:  1995-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.